Search results
Pipeline Moves: Investigator-led trial of Lilly’s merestinib in solid tumours terminated
Clinical Trials Arena via Yahoo Finance· 7 days agoThis week on Pipeline Moves, we kick off by looking at the termination of a Phase II...
Can Machines Invent Drugs: Patent Law Seeks to Prioritize Human Innovation as Artificial...
JD Supra· 6 days agoIn the 1950’s, Alan Turing famously asked, “Can machines think?” Decades later, artificial intelligence—a term coined after Turing’s death—has become...
Director, NLM - Bethesda, Maryland job with National Library of Medicine - Office of the Director |...
Nature· 5 days agoTHE POSITION: The National Institutes of Health (NIH) is seeking exceptional candidates for the position of Director, National Library of Medicine (NLM). NLM is one of 27 Institutes and Centers ...
Lenire from Neuromod delivers tinnitus improvement 'not demonstrated for any other treatment,'...
WTNH-TV New Haven· 7 days ago'Textbook of Tinnitus' is a comprehensive textbook that describes tinnitus, how it is caused, and...
HIV Risk and Interest in Preexposure Prophylaxis in Justice-Involved Persons
Centers for Disease Control and Prevention· 9 hours agoHIV Risk and Interest in Preexposure Prophylaxis
Angle PLC Announces New Commercial Agreement with Large Pharma
Digital Journal· 3 days agoANGLE commissioned to develop a Parsortix-based Androgen Receptor detection assay for use in prostate cancer studies GUILDFORD, SURREY / ACCESSWIRE / May 3, 2024 / ANGLE plc (AIM:AGL)(OTCQX: ...
Spring Has Sprung Obviousness Trends from the Federal Circuit
The National Law Review· 4 days agoThere have been only a few precedential decisions from the Federal Circuit related to obviousness...
MedStar Health Launches Participation in Phase 3 MAGNITUDE Gene-Editing Study with First U.S. Heart...
Newswise· 4 days agoWashington, D.C., May 2, 2024 – The first U.S. heart patient involved in a study for a new...
New studies reveal underrepresentation of women and Hispanic population in the treatment of...
Medical Xpress· 4 days agoSevere PAD that leads to CLTI affects two million patients in the United States, with 25% of them requiring an amputation within a year after diagnosis. Despite an uptick in recent research ...
Amgen axes obesity asset after phase 1 results, zooms in on MariTide
FierceBiotech· 3 days agoAmgen is axing obesity candidate AMG 786 and going all in on later-stage asset MariTide. “Given the...